Core Alternative Capital Enovis Corp Transaction History
Core Alternative Capital
- $484 Million
- Q2 2024
A detailed history of Core Alternative Capital transactions in Enovis Corp stock. As of the latest transaction made, Core Alternative Capital holds 10 shares of ENOV stock, worth $432. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 10
-0.0%
Holding current value
$432
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ENOV
# of Institutions
301Shares Held
61.6MCall Options Held
1.63MPut Options Held
576K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.64MShares$287 Million0.19% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$235 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$231 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.15MShares$136 Million0.04% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH3MShares$130 Million0.54% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.34B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...